Xtx Topco LTD Amneal Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

$1.3 Billion
Q3 2024

A detailed history of Xtx Topco LTD transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 22,210 shares of AMRX stock, worth $181,677. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,210

Previous 32,272 31.18%

Holding current value

$181,677

Previous $204,000 9.8%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $64,598 - $88,847	-10,062 Reduced 31.18%	22,210 $184,000
Q2 2024 Aug 12, 2024	SELL	$5.36 - $7.11 $11,416 - $15,144	-2,130 Reduced 6.19%	32,272 $204,000
Q1 2024 May 13, 2024	SELL	$5.24 - $6.34 $78,547 - $95,036	-14,990 Reduced 30.35%	34,402 $208,000
Q4 2023 Feb 13, 2024	BUY	$3.36 - $6.21 $23,903 - $44,177	7,114 Added 16.83%	49,392 $299,000
Q3 2023 Nov 13, 2023	BUY	$2.76 - $4.59 $26,890 - $44,720	9,743 Added 29.95%	42,278 $178,000
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $190,143 - $443,191	-142,965 Reduced 81.46%	32,535 $100,000
Q1 2023 May 12, 2023	SELL	$1.27 - $2.7 $20,322 - $43,205	-16,002 Reduced 8.36%	175,500 $243,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $375,343 - $499,820	191,502 New	191,502 $381,000
Q1 2022 May 13, 2022	SELL	$3.9 - $4.89 $92,593 - $116,098	-23,742 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.95 - $5.85 $44,907 - $66,508	11,369 Added 91.89%	23,742 $114,000
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $52,280 - $68,413	-12,130 Reduced 49.5%	12,373 $66,000
Q2 2021 Aug 12, 2021	BUY	$5.12 - $6.82 $125,455 - $167,110	24,503 New	24,503 $125,000

Others Institutions Holding AMRX

# of Institutions

192

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.24B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account